Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Not-So-Happy New Year: Device Tax Not Addressed In Fiscal Cliff Law

This article was originally published in The Gray Sheet

Executive Summary

There’s no mention of a device tax delay or repeal in the measure signed by President Obama Jan. 2, and the new law contains some Medicare payment cuts as one-year “Doc Fix” pay-fors.

You may also be interested in...

News Briefs: Panel OKs Sleep Apnea Stimulator; Two Stryker Buys; TAVR Updates

FDA panel unanimously endorses Inspire upper airway stimulator. Stryker buys Berchtold and Pivot. First randomized U.S. study of embolic protection during transcatheter aortic valve replacement approved. More news.

Correction Means Lower Medicare Outpatient Rates Than Expected For Stereotactic Radiosurgery

A correction notice issued by CMS to fix technical errors in the 2014 draft hospital outpatient prospective payment system cut its payment proposal for stereotactic radiosurgery by about $3,000 compared to a proposed rule issued in July.

News In Brief

New device tax repeal bills; 2012 VC funding data; more news.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts